Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment (Q39997445)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

multicenter clinical trial

0 references

Alzheimer's disease

0 references

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Eugeen Vanmechelen

9

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Johannes Kornhuber

10

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

object named as

J Wiltfang

11

0 references

Henrik Zetterberg

6

object named as

H Zetterberg

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1

object named as

K Blennow

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

14

object named as

W Maier

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Lennart Minthon

4

object named as

L Minthon

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

7

object named as

P Lewczuk

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

20

object named as

L Frölich

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

author name string

G De Meyer

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

A Wallin

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

H Vanderstichele

8

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

KND-Study Group

12

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

I Heuser

13

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

C Luckhaus

15

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

E Rüther

16

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

M Hüll

17

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

H Jahn

18

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

H J Gertz

19

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

H Hampel

21

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

R Pernetzki

22

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

publication date

1 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

The Journal of Nutrition, Health and Aging

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

205-208

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

https://scigraph.springernature.com/pub.10.1007/s12603-009-0059-0

0 references

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal changes of CSF biomarkers in memory clinic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma amyloid beta protein is elevated in late-onset Alzheimer disease families

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma amyloid-β concentrations in Alzheimer's disease: an alternative hypothesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The German Competence Net Dementias: standard operating procedures for the neurochemical dementia diagnostics

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal stability of CSF biomarkers in Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma amyloid-beta concentrations in Alzheimer's disease: an alternative hypothesis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma antibodies to Abeta40 and Abeta42 in patients with Alzheimer's disease and normal controls.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma Abeta in Alzheimer's disease--up or down?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition

1 reference

https://pubmed.ncbi.nlm.nih.gov/19262954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12603-009-0059-0

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

release_xgtwc6pj6bgrxppnzuw2odu5q4

1 reference

https://api.fatcat.wiki/v0/release/xgtwc6pj6bgrxppnzuw2odu5q4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39997445&oldid=1882162221"